|
ACER2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.42770000000015E-05 |
| Normal-vs-Stage3 |
9.83000003618173E-09 |
| Normal-vs-Stage4 |
5.6332999999964E-05 |
| Stage1-vs-Stage2 |
1.585630E-01 |
| Stage1-vs-Stage3 |
1.228590E-01 |
| Stage1-vs-Stage4 |
9.523100E-03 |
| Stage2-vs-Stage3 |
8.665200E-01 |
| Stage2-vs-Stage4 |
4.801600E-01 |
| Stage3-vs-Stage4 |
2.995600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.397300E-04 |
| Normal-vs-Asian |
7.233100E-04 |
| Caucasian-vs-AfricanAmerican |
9.427200E-01 |
| Caucasian-vs-Asian |
2.672400E-01 |
| AfricanAmerican-vs-Asian |
4.916400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.26789944998995E-10 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
6.841800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63302704692114E-12 |
| Normal-vs-Age(41-60Yrs) |
1.7883472480662E-12 |
| Normal-vs-Age(61-80Yrs) |
2.63879999962136E-07 |
| Normal-vs-Age(81-100Yrs) |
2.013400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.616500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.257300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.360300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.196600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.935900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.231400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.919400E-01 |
| Classical-VS-Follicular |
4.12060000000158E-05 |
| Classical-VS-Other |
4.618200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.040810E-01 |
| Tall-VS-Other |
7.236800E-01 |
| Tall-VS-Normal |
1.158590E-04 |
| Follicular-VS-Other |
6.295400E-01 |
| Follicular-VS-Normal |
1.783100E-04 |
| Other-VS-Normal |
2.327800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.29496454962464E-14 |
| Normal-vs-N1 |
4.35269999999877E-05 |
| N0-vs-N1 |
6.277200E-01 |
|
|
